SUMMARY
- Israeli equities had a strong start to 2026, with the TA-125 Index rising 9% in January, outperforming global markets as foreign investor participation and trading volumes increased materially.
- Macroeconomic conditions remained supportive, with solid fourth quarter growth, continued strength in high-tech exports, contained inflation and a stronger shekel reinforcing confidence in the domestic outlook.
- The Fund returned 6.1% (Class A, AUD) and 6.1% (Class B, USD), with strong contributions from Camtek, Azrieli Group, Teva and Nayax, partly offset by weakness in ICL and an underweight position in the banking sector.
The team will be visiting Australia in March for a series of investor meetings. Investors interested in arranging a discussion are welcome to Contact Us for more details.




